Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin.

Warren, Mark L; Chaykin, Louis B; Jabbour, Serge; Sheikh-Ali, Mae; Hansen, Charlotte T; Nielsen, Thor S S; Norwood, Paul

Warren, Mark L; Chaykin, Louis B; Jabbour, Serge; Sheikh-Ali, Mae; Hansen, Charlotte T; Nielsen, Thor S S; Norwood, Paul.

Afiliación

Warren ML; Physicians East, Greenville, NC.
Chaykin LB; Meridien Research, Bradenton, FL.
Jabbour S; Jefferson University Hospitals, Philadelphia, PA.
Sheikh-Ali M; University of Florida Health, Jacksonville, FL.
Hansen CT; Novo Nordisk A/S, Søborg, Denmark.
Nielsen TSS; Novo Nordisk A/S, Søborg, Denmark.
Norwood P; Valley Research, Fresno, CA.

Clin Diabetes ; 35(2): 90-95, 2017 Apr.

Article en En | MEDLINE | ID: mdl-28442823

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Clin Diabetes Año: 2017 Tipo del documento: Article País de afiliación: Nueva Caledonia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google